Paterson And Walton Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.34 M
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
- Revenue Growth %
- Profit Growth -13.86%
- Ebitda -13.86%
- Net Worth -0.49%
- Total Assets -0.49%
About Paterson And Walton Pharma
Paterson And Walton Pharma Private Limited (PAWPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 October 1994 and has a history of 30 years and four months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.34 M.
The company currently has active open charges totaling ₹1.50 M.
Prakash Shah and Bharti Shah serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999MH1994PTC082434
- Company No.
082434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Paterson And Walton Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Shah  | Director | 27-Oct-1994 | Current |
| Bharti Shah | Director | 27-Oct-1994 | Current |
Financial Performance of Paterson And Walton Pharma.
Paterson And Walton Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 13.86% decrease in profit. The company's net worth dipped by a decrease of 0.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paterson And Walton Pharma?
In 2018, Paterson And Walton Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- The Credit Bombay Co-Operative Bank Ltd. : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2001 | The Credit Bombay Co-Operative Bank Ltd. | ₹1.50 M | Open |
How Many Employees Work at Paterson And Walton Pharma?
Unlock and access historical data on people associated with Paterson And Walton Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paterson And Walton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paterson And Walton Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.